Roche Diagnostics Purchases Microarray Instrument and Accessory Assets from BioMicro Systems
Roche Diagnostics has purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow. These assets consist of key instrumentation in the Roche NimbleGen microarray workflow. Also included in this purchase are array accessories covering all mixers designed for the Roche NimbleGen high-density microarray portfolio. Roche Diagnostics will continue to provide global sales, service, and support for all products in the NimbleGen microarray workflows.
With the purchase of these assets, Roche Diagnostics will transfer the manufacturing capabilities for the above products to an in-house manufacturing facility. According to Andreas Görtz, VP of Marketing at Roche NimbleGen, ‘The acquired products are integral to the high quality data the NimbleGen array workflow provides researchers worldwide. Acquiring these assets will allow Roche complete control over the production, support and service of these products to ensure continued timely distribution, full support and the high level of service our customers have grown to expect from Roche.”
Most read news
Other news from the department business & finance
These products might interest you

2mag Magnetic Stirrers Catalogue 2024 by 2mag
Wear-free magnetic stirrers for laboratory and cell culture
Request the 2mag catalogue 2024 with innovative stirring solutions now

YSTRAL Conti-TDS by ystral
YSTRAL Conti-TDS: The No. 1 in Powder Wetting
Induct, wet and disperse powder

Drive Units for Pro Mixer by Sartorius
Magnetic disposable agitator without surface contact perfect for biopharmaceutical process
Improved efficiency in cell harvesting and buffer preparation through advanced technology

Flexsafe® Bag for Pro Mixer without top port - 1500 L by Sartorius
Efficient bioprocess optimisation: 1500 L Flexsafe® Pro Mixer Bag
Improved mixing processes and easy handling thanks to ergonomic design and inline sensors

Innovative Magnetic Stirrers by 2mag
Magnetic stirrer of the future - for laboratories and pilot plants
Individually configurable, 100 % wear-free, 3-year guarantee

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Scientists create compounds that dramatically alter biological clock and lead to weight loss - The new molecules could lead to unique treatments for obesity, diabetes, high cholesterol, and sleep disorders
QIAGEN and Bio*One Capital Enter into Joint Venture to Develop Molecular Diagnostics Products - Assay development centre for Singapore will support QIAGEN in the market for molecular testing solutions
Researchers Identify Genetic Mutation That May Alter Patients' Response to Cancer Therapeutics - Recurring mutation found in breast, colorectal and ovarian cancers
OctoPlus wins drug development and manufacturing contract from Danish pharmaceutical company
